Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cholic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104193792B reveals a one-step microwave-assisted conversion of chenodeoxycholic acid. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity ursodeoxycholic acid.
Advanced refining method for Hyodeoxycholic Acid ensures high purity and safety. Ideal for pharmaceutical intermediates manufacturing with reduced costs and scalable supply chain solutions.
Patent CN103755764B details a scalable synthetic route for taurocholic acid ensuring high purity and cost efficiency for global pharmaceutical supply chains.
Novel enzymatic method for UDCA and TUDCA from pig bile. High purity, scalable process. Reliable pharmaceutical intermediates supplier for cost reduction.
Patent CN111285914B reveals a high-yield Obeticholic Acid synthesis using Weinreb amide protection, offering superior purity and scalable manufacturing for pharmaceutical intermediates.
Novel LDA-free synthesis for Obeticholic Acid intermediates reduces cost and complexity. Scalable pharmaceutical intermediates manufacturing with high purity and supply reliability.
Novel patent CN108264532A details mild obeticholic acid synthesis reducing hazardous reagents. Enhances supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.
Novel hyodesoxycholic acid route ensures safety and yield. Ideal for pharmaceutical intermediates manufacturing cost reduction and supply chain reliability.
Novel synthetic route for lithocholic acid using hyodesoxycholic acid ensures higher yield and safety. Ideal for pharmaceutical intermediate suppliers seeking cost-effective scalable production solutions.
Patent CN116836214B details a plant-based synthesis route for 7-ketolithocholic acid intermediates, offering high purity and supply chain security for pharmaceutical manufacturing.
Patent CN115806578A details a novel Nor-UDCA synthesis from Phocacholic Acid using CO2-assisted oxidation, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112341512A details a novel route converting seal cholic acid to chenodeoxycholic acid, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply reliability.
Novel aldol condensation route for obeticholic acid intermediate. High yield, scalable process offering cost reduction in API manufacturing and supply chain reliability.
Patent CN120081889B reveals a one-pot hydrogenation method for high-purity chenodeoxycholic acid, offering significant cost reduction in API manufacturing and scalable production.
Novel patent CN105315320A enables scalable Obeticholic Acid production with enhanced purity and reduced operational risks for global supply chains.
Patent CN107573396B details a novel two-step chromatography method achieving >97.5% purity CDCA. Ideal for reliable pharmaceutical intermediates supply chains.
Novel plant-derived synthesis route for Ursodeoxycholic Acid ensures high purity and supply continuity. Ideal for pharmaceutical intermediates manufacturing.
Patent CN111410675A reveals a low-cost oxidation method for 3 7-diketocholanic acid. Enhances purity and yield for pharmaceutical intermediates manufacturing supply chains.
Novel two-step synthesis of lithocholic acid from hyodesoxycholic acid offers high yield and scalable production for pharmaceutical intermediate supply chains globally.
Patent CN106397522A reveals stable TBDMS intermediate route. Reduces cost in API manufacturing. Reliable pharmaceutical intermediates supplier for scale-up.